Introduction
============

Osteoarthritis (OA) is a comment disease that affects many major joints including the hip, spine, knee and the hand ([@b1-mmr-16-04-5175],[@b2-mmr-16-04-5175]). OA leads to severe functional and emotional burdens to patients and causes heavy economic burdens ([@b3-mmr-16-04-5175]). Hand osteoarthritis (HOA) is one of the most common kinds of OA and HOA is a leading cause of disability of the hands. The incidence of HOA is \~20% in people aged 65 or older ([@b4-mmr-16-04-5175]).

HOA is considered as a primarily degenerative process with inflammation ([@b5-mmr-16-04-5175]), and degradation of articular cartilage is the hallmark of HOA. The cartilage degradation process of the knee and hip joints has been well investigated using animal models or human chondrocyte culture. However, the molecular mechanism of HOA is largely unknown. Limited by different anatomical shapes and mechanical requirements, findings from knee or hip joints cannot be simply applied to other joints. For HOA, Stradner *et al* ([@b6-mmr-16-04-5175]) successfully established a chondrocyte culture of proximal interphalangeal (PIP) cartilage, and demonstrated that chondrocytes from PIP and knee joints have distinct expression patterns of protein-coding genes.

Previous evidence has indicated that non-coding RNAs serve important roles in various biological processes including carcinogenesis, cell differentiation, metabolism, and immunity responses ([@b7-mmr-16-04-5175]--[@b12-mmr-16-04-5175]). Long non-coding RNA (lncRNA) is a kind of non-coding RNA transcript, which is \>200 nt long and does not encode proteins ([@b7-mmr-16-04-5175]). Researchers have demonstrated that lncRNAs are involved in regulating the expression levels of various factors involved in the pathological process of OA, including maternally expressed 3 ([@b13-mmr-16-04-5175]), imprinted maternally expressed transcript ([@b14-mmr-16-04-5175]) and HOX transcript antisense RNA ([@b15-mmr-16-04-5175]). However, the lncRNA expression profile from hip and knee joints cannot be simply applied to HOA, and the expression pattern of lncRNA in HOA remains unknown. Therefore, the present study performed a bioinformatics analysis to systematically analyze lncRNA expression profile in the human cartilage of the PIP finger joints by annotation of microarray data to improve the understanding about the pathology of HOA.

Materials and methods
=====================

### Dataset selection

The gene expression data used in the current study was obtained from the publicly available Gene Expression Omnibus (GEO) database ([www.ncbi.nlm.nih.gov/geo/](www.ncbi.nlm.nih.gov/geo/)). This GSE68038 dataset was identified and analyzed, which contains 3 samples of knee chondrocytes and 3 samples of PIP chondrocytes. The GSE68038 dataset was based on the Affymetrix Human Gene 2.0 ST Array \[transcript (gene) version\] (Affymetrix; Thermo Fisher Scientific, Inc.). The raw CEL files were downloaded and quantile normalized and background adjusted using Robust Multichip Average (Windows version) software v1.20.0 ([@b16-mmr-16-04-5175]). After normalization, the expression value of each probe was obtained. The normalized data were then analyzed with Significant Analysis of Microarray software v4.01 ([@b17-mmr-16-04-5175]). Unpaired t-test was used to calculate differentially expressed genes and P\<0.05 was considered to indicate a statistically significant difference. Differentially expressed lncRNAs were clustered and visualized by Cluster 3.0 software (<http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm>).

### Annotation of lncRNA probes

To identify probe sets that target lncRNA transcripts, the BioMart data portal ([www.biomart.org/](www.biomart.org/)) was used to download annotations of lncRNA probes. Following this, the probe sets were filtered according to Ensemble transcript type, and transcripts with 'antisense', 'processed_transcripts', 'lincRNA', 'non_sense_mediated_decay', 'sense intronic' and 'sense overlapping' were selected as lncRNA ([@b18-mmr-16-04-5175],[@b19-mmr-16-04-5175]). After creation of annotation file, the differentially probe sets were matched and annotated.

### Co-expression network construction

The co-expression network of lncRNA protein-coding genes was built to identify the interactions between coding genes and lncRNA ([@b20-mmr-16-04-5175]). Differentially expressed lncRNAs and protein-coding genes with P\<0.01 were used to construct the co-expression network, and the normalized expression values were retrieved. For each pair of coding gene-lncRNA, coding-coding genes or lncRNA-lncRNA, the P value of Pearson correlation and significant correlation pairs (P\<0.05) were used to construct the network ([@b21-mmr-16-04-5175]). Cytoscape software v3.3.0 was utilized to visualize the co-expression network ([www.cytoscape.org/](www.cytoscape.org/)).

### Functional enrichment analysis

The gene functional enrichment analysis was performed by the Database for Annotation, Visualization and Integrated Discovery online tools (<http://david.ncifcrf.gov/>) ([@b22-mmr-16-04-5175]). P\<0.05 and false discovery rate\<0.05 was considered as significant enrichment.

Results
=======

Gene expression profiles of chondrocytes were analyzed with Affymetrix Human Gene 2.0 ST Arrays. After annotation, \~18,000 probes mapped to lncRNAs were identified. According to the statistical threshold, 1,172 differentially expressed lncRNAs were identified. Compared with chondrocytes from knee joints, 534 lncRNAs were upregulated and 638 lncRNAs were downregulated in chondrocytes from PIP joints. The expression patterns of lncRNAs were different between chondrocytes from knee and PIP joints, and the top 100 differentially expressed lncRNAs are presented as a heat map ([Fig. 1](#f1-mmr-16-04-5175){ref-type="fig"}). As presented, a set of lncRNAs were significantly differentially expressed between PIP and knee joints. The detailed information of 20 most upregulated and downregulated lncRNAs are presented in [Table I](#tI-mmr-16-04-5175){ref-type="table"}. Compared with knee joints chondrocyte, ENST00000451530 was mostly upregulated in chondrocytes from PIP, and ENST00000462445 was mostly downregulated.

Co-expression networks of lncRNA and protein-coding genes may provide information to infer the biological function of lncRNA, as genes in the same signaling pathway or with the same function may have similar expression patterns. Additionally, co-expression networks have been widely used to predict the potential biological function of lncRNAs. Therefore, a co-expression network was built between lncRNA and protein-coding genes. As presented in [Fig. 2A](#f2-mmr-16-04-5175){ref-type="fig"}, lncRNAs and protein-coding genes are closely connected. In the co-expression network, RP11-6E9.4 (ENST00000508955) and RP11-713P17.3 (ENST00000529070) were 2 lncRNAs that co-expressed with \>30 protein-coding genes. In addition, many inflammation-associated genes were co-expressed with these lncRNAs, including interleukin (IL)-7R, IL-19 and chemokine (C-C) motif ligand 1. On the other hand, several Wnt pathway genes, including Wnt5A, were also co-expressed with these lncRNAs.

Co-expression networks are a potential method to predict lncRNA function, as genes involved in the same biological processes are usually co-expressed. Therefore, a functional enrichment analyses for protein-coding genes in the co-expression network was performed to further predict their biological functions. As presented in [Fig. 2C and D](#f2-mmr-16-04-5175){ref-type="fig"}, gene ontology analyses demonstrated that these protein-coding genes were significantly associated with bone morphogenesis, bone development, skeletal system development and cartilage development, suggesting these protein-coding genes and lncRNAs may be involved in OA pathogenesis.

Discussion
==========

Articular cartilage degradation is a hallmark of OA. Human chondrocyte culture has been extensively used to investigate the cartilage degradation of knee and hip joints. However, little is known is about the cartilage degradation in HOA, and findings from hip and knee joints cannot be simply applied to HOA due to different anatomical shapes and mechanical requirements between joints ([@b23-mmr-16-04-5175],[@b24-mmr-16-04-5175]).

The present study compared lncRNA expression profiles between chondrocytes from PIP and knee joints. The results demonstrated that chondrocytes from PIP and knee joints have different lncRNA expression patterns. Compared with chondrocytes from knee joints, 534 lncRNAs were upregulated and 638 lncRNAs were downregulated in chondrocytes from PIP joints. The different expression profile of lncRNA between chondrocyte from PIP and knee joints supported previous reports that lncRNA expression is highly temporally and specially specific ([@b7-mmr-16-04-5175]). Therefore, these differentially expressed lncRNAs in PIP joints may be involved in the biological function of chondrocytes, and the pathological process of HOA.

Previous research has investigated the lncRNA expression profile in patients with rheumatoid arthritis ([@b25-mmr-16-04-5175],[@b26-mmr-16-04-5175]), and it was concluded that lncRNA may contribute to the pathogenesis of rheumatoid arthritis ([@b26-mmr-16-04-5175]). Compared with these studies in rheumatoid arthritis, lncRNA expression in HOA was analyzed with bioinformatics analyses, and the potential association between lncRNAs and coding genes was inferred. However, HOA and rheumatoid arthritis have different pathologies and clinical features; therefore, findings between the two cannot be easily compared.

Co-expression networks between lncRNA and protein-coding genes were constructed to infer the potential function of these lncRNAs. GO enrichment analyses demonstrated that protein-coding genes in the co-expression network are associated with many skeletal system-specific items, including bone, cartilage and skeletal system development. The results suggested that these lncRNAs were highly likely involved in these biological processes, and these lncRNAs may also serve important roles in the pathological process of HOA.

Subsequently, the present study demonstrated that RP11-6E9.4 (ENST00000508955) and RP11-713P17.3 (ENST00000529070) were co-expressed with the most protein-coding genes. Compared with chondrocytes from knee joints, RP11-6E9.4 and RP11-713P17.3 were significantly downregulated in PIP joints. In addition, we constructed a co-expression network of coding genes and lncRNAs and found RP11-6E9.4 and RP11-713P17.3 were co-expressed with several inflammation and cartilage specific genes, including collagen type I alpha I and transcription factor SOX9 ([@b27-mmr-16-04-5175]). Therefore, RP11-6E9.4 and RP11-713P17.3 are potentially involved in the pathogenesis of OA; however, further experiments are required to validate the functional roles of these lncRNAs.

The biological function and molecular mechanism have been widely investigated in various biological and pathological processes. To the best of our knowledge, there is currently no literature on the expression profile of HOA in lncRNA. However, the present study has several limitations. Firstly, this is only a bioinformatics analysis; thus, these findings should be further validated by laboratory experiments. Secondly, the sample sizes analyzed were small, which might limit the application of these findings.

In conclusion, the present study demonstrated that chondrocytes from PIP joints have different lncRNA expression profiles. These findings may improve knowledge on the biological roles of lncRNA and the pathology of HOA.
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![Heat map of differentially expressed lncRNAs between chondrocytes from PIP and knee joints. Each row represents an lncRNA and each column represents a sample, the left 3 columns are chondrocytes from knee joints and the right 3 columns are chondrocytes from PIP joints; red, upregulated lncRNAs, green, downregulated lncRNAs. lncRNA, long non-coding RNA; PIP, proximal interphalangeal.](MMR-16-04-5175-g00){#f1-mmr-16-04-5175}

![(A) Co-expression network of lncRNAs and protein-coding genes. Yellow dots, lncRNAs; green dots, protein-coding genes; light red dots, centers of the sub-networks. (B) Enrichment plot of gene ontology results. Biological processes associated with bone and cartilage are highlighted with red, and grey dots are terms not associated with bone or cartilage. (C) Column chart of gene ontology results, and bone and cartilage-associated gene ontology terms are highlighted with red boxes. lncRNA, long non-coding RNA.](MMR-16-04-5175-g01){#f2-mmr-16-04-5175}

###### 

Differentially expressed lncRNAs between chondrocytes from PIP and knee joints.

  Ensembl gene ID   Ensembl transcript ID   Regulation (PIP vs. knee)   P-value    logFC      FC         Strand   Chromosome name   Transcript start (bp)   Transcript end (bp)   Transcript type
  ----------------- ----------------------- --------------------------- ---------- ---------- ---------- -------- ----------------- ----------------------- --------------------- -------------------------
  ENSG00000238258   ENST00000451530         Up                          0.000105   3.55224    11.73089   1        10                33211277                33213804              Antisense
  ENSG00000253357   ENST00000517346         Up                          0.00013    8.75114    430.8793   1        5                 1.68E+08                1.68E+08              Sense intronic
  ENSG00000260758   ENST00000562495         Up                          0.000197   1.14294    2.208306   −1       15                86078743                86079792              lincRNA
  ENSG00000226677   ENST00000554337         Up                          0.000212   1.05432    2.076739   1        14                34939324                34940332              Processed_pseudogene
  ENSG00000125430   ENST00000466596         Up                          0.000262   8.60867    390.3623   1        17                14301083                14349144              Nonsense_mediated_decay
  ENSG00000264425   ENST00000585107         Up                          0.000281   2.49343    5.631152   1        7                 1.01E+08                1.01E+08              miRNA
  ENSG00000231019   ENST00000430214         Up                          0.000307   0.59894    1.514603   1        13                88142867                88236082              lincRNA
  ENSG00000222276   ENST00000410344         Up                          0.000541   2.09069    4.259517   1        14                96384624                96384815              snRNA
  ENSG00000232677   ENST00000590657         Up                          0.000544   0.82319    1.769314   −1       19                36313067                36315737              lincRNA
  ENSG00000173267   ENST00000465679         Up                          0.000715   1.04375    2.061579   1        10                86958618                86962873              Processed_transcript
  ENSG00000257175   ENST00000548656         Up                          0.000781   1.4772     2.784079   −1       14                18634955                18637208              Processed_pseudogene
  ENSG00000256879   ENST00000535755         Up                          0.000794   2.73779    6.670477   −1       12                20361732                20370262              Antisense
  ENSG00000246876   ENST00000509105         Up                          0.000804   0.8389     1.788686   −1       4                 1.3E+08                 1.3E+08               lincRNA
  ENSG00000258285   ENST00000547006         Up                          0.000828   1.19266    2.285738   1        12                1.17E+08                1.17E+08              lincRNA
  ENSG00000233639   ENST00000413121         Up                          0.00085    0.68007    1.602217   −1       2                 1.05E+08                1.05E+08              lincRNA
  ENSG00000183760   ENST00000601575         Up                          0.001074   0.6835     1.606031   1        19                39083913                39111493              Nonsense_mediated_decay
  ENSG00000226277   ENST00000449119         Up                          0.001085   1.02464    2.034452   1        2                 421057                  422156                lincRNA
  ENSG00000104964   ENST00000592414         Up                          0.001142   0.65003    1.569201   −1       19                3052910                 3056768               Retained_intron
  ENSG00000249115   ENST00000587439         Up                          0.001171   0.52637    1.440301   1        19                35612744                35623609              Nonsense_mediated_decay
  ENSG00000129038   ENST00000566011         Up                          0.001176   2.30828    4.952922   1        15                73925989                73951919              Nonsense_mediated_decay
  ENSG00000122862   ENST00000462445         Down                        3.26E-05   −3.2672    0.103866   1        10                69088106                69104541              Processed_transcript
  ENSG00000207036   ENST00000384309         Down                        0.000144   −2.3052    0.202333   1        8                 70357347                70357448              misc_RNA
  ENSG00000212951   ENST00000473402         Down                        0.000315   −0.82787   0.56336    −1       9                 62532397                62532853              Unprocessed_pseudogene
  ENSG00000265520   ENST00000584165         Down                        0.000349   −1.70144   0.307479   −1       8                 17681578                17681657              miRNA
  ENSG00000215304   ENST00000562108         Down                        0.000371   −2.93247   0.13099    −1       15                32398956                32435233              Processed_transcript
  ENSG00000223929   ENST00000441598         Down                        0.000492   −0.70198   0.614728   −1       2                 60359720                60383036              lincRNA
  ENSG00000255366   ENST00000528139         Down                        0.000607   −3.02043   0.123242   1        8                 47190772                47193262              lincRNA
  ENSG00000178162   ENST00000424873         Down                        0.000674   −5.04991   0.030187   −1       2                 1.3E+08                 1.3E+08               Processed_transcript
  ENSG00000236166   ENST00000430428         Down                        0.000747   −1.67661   0.312817   1        6                 1.32E+08                1.32E+08              lincRNA
  ENSG00000226853   ENST00000444196         Down                        0.000786   −1.35524   0.39087    1          2               1.74E+08                1.74E+08              lincRNA
  ENSG00000207009   ENST00000384282         Down                        0.000931   −1.31169   0.402849   −1         4               1683420                 1683529               Misc_RNA
  ENSG00000188257   ENST00000469162         Down                        0.001124   −8.2513    0.003282   −1         1               19975431                19979607              Processed_transcript
  ENSG00000262117   ENST00000571259         Down                        0.001136   −0.75445   0.592772   −1       16                11819829                11828828              lincRNA
  ENSG00000273259   ENST00000553947         Down                        0.001138   −7.74996   0.004645   1        14                94592058                94624646              Nonsense_mediated_decay
  ENSG00000255480   ENST00000529078         Down                        0.001249   −3.04775   0.12093    1        11                30425552                30429268              Antisense
  ENSG00000243478   ENST00000487742         Down                        0.001249   −0.88687   0.540786   1          2               2.01E+08                2.01E+08              Unitary_pseudogene
  ENSG00000258827   ENST00000554595         Down                        0.001278   −0.43912   0.737584   −1       14                37097062                37098563              Sense_intronic
  ENSG00000273172   ENST00000576171         Down                        0.001315   −0.49803   0.708073   −1       17                183824                  191587                lincRNA
  ENSG00000211836   ENST00000390484         Down                        0.001331   −0.4889    0.712568   1        14                22482287                22482346              TR_J\_gene
  ENSG00000275890   ENST00000616723         Down                        0.001356   −5.29061   0.025549   1        GL000205.2        9151                    9226                  miRNA

lincRNA, long intervening non-coding RNA; miRNA, microRNA; PIP, proximal interphalangeal; lncRNA, long non-coding RNA; FC, fold change; snRNA, small nuclear RNA.
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